Nathan A Boggs

M.D. Ph.D.

Commander, Public Health

Department of Primary Appointment:
School of Medicine
Medicine
Title
Allergy Division Director
Location: Uniformed Services University of the Health Sciences, Bethesda, MD
Research Interests:
Systemic Mastocytosis, Inborn Errors of Immunity
Genetics, Myeloid Neoplasms, Allergy
Email
nathan.boggs@usuhs.edu
Office Phone
301-295-7988
Department Website
Department of Medicine

Education

Allergy & Immunology Fellowship, National Institute of Allergy and Infectious Diseases (2019)
Internal Medicine Residency, Yale-New Haven Hospital (2017)
M.D. Uniformed Services University (2014)
Ph.D. Plant Molecular Biology, Cornell University (2009)
B.S. Plant & Soil Science, University of Vermont (2003)

Biography

Dr. Nathan Boggs developed an international clinical registry for Tricare beneficiaries known, or suspected to have, the myeloid neoplasm systemic mastocytosis. The registry is designed to reduce the time to diagnosis and improve the care of those who are diagnosed. Dr. Boggs has developed clinical and research collaborations with ARUP labs and the National Institutes of Health (NIH) Clinical Center and helped Walter Reed obtain a Center of Excellence designation by the American Initiative in Mast Cell Diseases (AIM).

Dr. Boggs is principal investigator (PI) of multiple funded research studies. One study, in collaboration with Drs. Clifton Dalgard and Andrew Snow at USU, aims to improve genetic diagnosis rates compared to standard of care genetic testing for patients with inborn errors of immunity and mastocytosis. The study utilizes a whole genome and RNA sequencing approach. A second study is assessing the genetic underpinning of urticaria. Dr. Boggs it also the Walter Reed site PI for the SUMMIT clinical trial investigating bezuclastinib for non-advanced systemic mastocytosis.

https://aimcd.net/centers/
https://clinicaltrials.gov/study/NCT05186753

Representative Bibliography

Biosketch Link
https://www.ncbi.nlm.nih.gov/myncbi/nathan.boggs.2/bibliography/public/

McMurray JC, Pacheco CS, Schornack BJ et al. Standardized indolent systemic mastocytosis evaluations across a healthcare system: implications for screening accuracy. Blood. 2024.

Soderstrom MA, Miller MA, Wang Q et al. Vaccine utilization and overwhelming post-splenectomy infection risk factors in two asplenia cohorts. Haematologica. 2023

Boggs NA, Sun X, Lyons JJ et al. Challenges in Applying Diagnostic Criteria for Systemic Mastocytosis. Blood Advances. 2023

Waters AM, Park HJ, Weskamp AL et al. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System. JACI-In Practice. 2022.

Boggs NA and Rao VK. The role of bone marrow evaluation in clinical allergy and immunology practice: When and why? JACI-In Practice. 2020.